Interleukin-6 and Its Receptor: A Paradigm for Cytokines-Reference-Cited by-同舟云学术

Interleukin-6 and Its Receptor: A Paradigm for Cytokines

Published:1992-10-23 Issue:5082 Volume:258 Page:593-597
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Kishimoto Tadamitsu¹,Akira Shizuo¹,Taga Tetsuya¹

Affiliation:

1. Department of Internal Medicine Ill, Osaka University Medical School Osaka City 553, and Institute for Molecular and Cellular Biology, Osaka University, Suita City 565, Japan

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference127 articles.

1. AKIRA, S, A NUCLEAR FACTOR FOR IL-6 EXPRESSION (NF-IL6) IS A MEMBER OF A C/EBP FAMILY, EMBO JOURNAL 9: 1897 (1990).

2. ASANO, S, INVIVO EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-6 IN PRIMATES - STIMULATED PRODUCTION OF PLATELETS, BLOOD 75: 1602 (1990).

3. AUSTIN, L, STIMULATION OF MYOBLAST PROLIFERATION IN CULTURE BY LEUKEMIA INHIBITORY FACTOR AND OTHER CYTOKINES, JOURNAL OF THE NEUROLOGICAL SCIENCES 101: 193 (1991).

4. BAZAN, J.F., HEMATOPOIETIC RECEPTORS AND HELICAL CYTOKINES, IMMUNOLOGY TODAY 11: 350 (1990).

5. BAZAN, J.F., STRUCTURAL DESIGN AND MOLECULAR EVOLUTION OF A CYTOKINE RECEPTOR SUPERFAMILY, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 87: 6934 (1990).

Cited by 840 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of New Diffuse Large B Cell Lymphoma Mouse Models;Cancers;2024-08-29

2. Immunology and targeted therapy in Castleman disease;Expert Review of Clinical Immunology;2024-05-27

3. Mystery of COVID 19: Focusing on important ncRNAs and effective signaling pathways;Pathology - Research and Practice;2024-03

4. Supplementation of nicotinamide mononucleotide diminishes COX-2 associated inflammatory responses in macrophages by activating kynurenine/AhR signaling;Free Radical Biology and Medicine;2024-03

5. Natural products as IL‐6 inhibitors for inflammatory diseases: Synthetic and SAR perspective;Medicinal Research Reviews;2024-02-02